Vincent Aurentz - Feb 21, 2025 Form 3 Insider Report for Inhibikase Therapeutics, Inc. (IKT)

Role
Director
Signature
/s/ Garth Lees-Rolfe, attorney-in-fact
Stock symbol
IKT
Transactions as of
Feb 21, 2025
Transactions value $
$0
Form type
3
Date filed
2/25/2025, 04:05 PM
Previous filing
Dec 2, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney